PA007187: In Vivo Grade Recombinant Chimeric Human IgG1 kappa Isotype Control Antibody

The in vivo grade recombinant chimeric human IgG1 isotype control antibody was produced in CHO cells.
Applications: an isotype-matched negative control for human IgG1 kappa antibodies used in ELISA, Western Blot (WB), Flow Cytometry (Flow), Immunoprecipitation (IP), Immunohistochemistry (Paraffin) (IHC (P)), Immunohistochemistry (Frozen) (IHC (F)), and in vivo animal model research.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.

PA007188: In Vivo Grade Recombinant Chimeric Human IgG1-D265A kappa Isotype Control Antibody

The in vivo grade recombinant chimeric human IgG1-D265A kappa isotype control mutant was produced in mammalian cells.
Applications: an isotype-matched negative control for human IgG1 D265A kappa antibodies used in ELISA, Western Blot (WB), Flow Cytometry (Flow), Immunoprecipitation (IP), Immunohistochemistry (Paraffin) (IHC (P)), Immunohistochemistry (Frozen) (IHC (F)), and in vivo animal model research.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.

PA007189: In Vivo Grade Recombinant Chimeric Human IgG1-N297A kappa Isotype Control Antibody

The in vivo grade recombinant chimeric human IgG1-N297A kappa isotype control mutant was produced in mammalian cells.
Applications: an isotype-matched negative control for human IgG1 N297A kappa antibodies used in ELISA, Western Blot (WB), Flow Cytometry (Flow), Immunoprecipitation (IP), Immunohistochemistry (Paraffin) (IHC (P)), Immunohistochemistry (Frozen) (IHC (F)), and in vivo animal model research.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.

PA007190: In Vivo Grade Recombinant Chimeric Human IgG1-L234A L235A P329G (hIgG1 LALAPG) kappa Isotype Control Antibody

The in vivo grade recombinant chimeric human IgG1-L234A L235A P329G (hIgG1 LALAPG, Fc silenced) kappa isotype control mutant was produced in CHO cells.
Applications: an isotype-matched negative control for human IgG1 LALAPG kappa antibodies used in ELISA, Western Blot (WB), Flow Cytometry (Flow), Immunoprecipitation (IP), Immunohistochemistry (Paraffin) (IHC (P)), Immunohistochemistry (Frozen) (IHC (F)), and in vivo animal model research.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.

PA007191: In Vivo Grade Recombinant Chimeric Human IgG1-D265A N297A (hIgG1 DANA) kappa Isotype Control Antibody

The in vivo grade recombinant chimeric human IgG1-D265A N297A (hIgG1 DANA) kappa isotype control mutant was produced in mammalian cells.
Applications: an isotype-matched negative control for human IgG1 DANA kappa antibodies used in ELISA, Western Blot (WB), Flow Cytometry (Flow), Immunoprecipitation (IP), Immunohistochemistry (Paraffin) (IHC (P)), Immunohistochemistry (Frozen) (IHC (F)), and in vivo animal model research.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.

PA007192: In Vivo Grade Recombinant Chimeric Human IgG1-S267E L328F (hIgG1 SELF) kappa Isotype Control Antibody

The in vivo grade recombinant chimeric human IgG1-S267E L328F (hIgG1 SELF, Fc activated) kappa isotype control mutant was produced in mammalian cells.
Applications: an isotype-matched negative control for human IgG1 SELF kappa antibodies used in ELISA, Western Blot (WB), Flow Cytometry (Flow), Immunoprecipitation (IP), Immunohistochemistry (Paraffin) (IHC (P)), Immunohistochemistry (Frozen) (IHC (F)), and in vivo animal model research.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.

PA004995-PA1473: Resistin Polyclonal Antibody

Rabbit Polyclonal Antibody;
Applications: WB, IH(P);
Reactivity: Mouse;
Isotype: Rabbit IgG.

PA002070-PA1818: IRF2 Polyclonal Antibody

Rabbit Polyclonal Antibody;
Applications: WB;
Reactivity: Human, Rat, Mouse;
Isotype: Rabbit IgG.

PA005343-PA1421: Fetuin A Polyclonal Antibody

Rabbit Polyclonal Antibody;
Applications: WB;
Reactivity: Human;
Isotype: Rabbit IgG.

C127P: Galcanezumab Biosimilar, CALCA/CGRP1/CALCB/CGRP2 Monoclonal Antibody

Recombinant Humanized IgG4 Monoclonal Antibody. 
Specificity/Sensitivity: The in vivo grade galcanezumab biosimilar specifically binds to the CALCA/CGRP1/CALCB/CGRP2 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by galcanezumab.

C120P: Tezepelumab Biosimilar, Human TSLP Monoclonal Antibody

Recombinant Humanized IgG2 lambda Monoclonal Antibody. 
Specificity/Sensitivity: The in vivo grade tezepelumab biosimilar specifically binds to the TSLP protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by tezepelumab.

C113P: Sotatercept Biosimilar, Anti-EDF Fusion Protein

Specificity/Sensitivity: The in vivo grade sotatercept biosimilar specifically binds to the EDF protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by sotatercept.

C116P: Romiplostim Biosimilar, Human TPO Fusion Protein

Specificity/Sensitivity: The in vivo grade romiplostim biosimilar specifically binds to the TPO protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by romiplostim.

C118P: Mepolizumab Biosimilar, Human IL-5 Monoclonal Antibody

Recombinant Humanized IgG1 kappa Monoclonal Antibody. 
Specificity/Sensitivity: The in vivo grade mepolizumab biosimilar specifically binds to the IL-5 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by mepolizumab.

C124P: Lecanemab Biosimilar, Human amyloid-beta Monoclonal Antibody

Recombinant Humanized IgG1 kappa Monoclonal Antibody. 
Specificity/Sensitivity: The in vivo grade lecanemab biosimilar specifically binds to the amyloid-beta protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by lecanemab.